Santhera Pharmaceuticals (Idebenone Business) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Santhera Pharmaceuticals (Idebenone Business) General Information

Description

Developer of small molecule specialty pharmaceutical products designed to meet the needs of children and adults living with mitochondrial disorders.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Marie-Curie Strasse 8
  • 79539 Lörrach
  • Germany
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Corporate Office
  • Marie-Curie Strasse 8
  • 79539 Lörrach
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Santhera Pharmaceuticals (Idebenone Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Santhera Pharmaceuticals (Idebenone Business)‘s full profile, request access.

Request a free trial

Santhera Pharmaceuticals (Idebenone Business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Santhera Pharmaceuticals (Idebenone Business)‘s full profile, request access.

Request a free trial

Santhera Pharmaceuticals (Idebenone Business) FAQs

  • Where is Santhera Pharmaceuticals (Idebenone Business) headquartered?

    Santhera Pharmaceuticals (Idebenone Business) is headquartered in Lörrach, Germany.

  • What industry is Santhera Pharmaceuticals (Idebenone Business) in?

    Santhera Pharmaceuticals (Idebenone Business)’s primary industry is Biotechnology.

  • Is Santhera Pharmaceuticals (Idebenone Business) a private or public company?

    Santhera Pharmaceuticals (Idebenone Business) is a Private company.

  • What is Santhera Pharmaceuticals (Idebenone Business)’s current revenue?

    The current revenue for Santhera Pharmaceuticals (Idebenone Business) is .

  • Who are Santhera Pharmaceuticals (Idebenone Business)’s investors?

    Santhera Pharmaceuticals Holding has invested in Santhera Pharmaceuticals (Idebenone Business).

  • When was Santhera Pharmaceuticals (Idebenone Business) acquired?

    Santhera Pharmaceuticals (Idebenone Business) was acquired on 28-Jul-2023.

  • Who acquired Santhera Pharmaceuticals (Idebenone Business)?

    Santhera Pharmaceuticals (Idebenone Business) was acquired by Chiesi Farmaceutici.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process